DEFM14A: Crescent to Acquire Vital Energy in All-Stock Merger

Sentiment:

Merger Announcement


Crescent Energy Company has agreed to acquire Vital Energy, Inc. through an all-stock merger, with Vital stockholders receiving 1.9062 shares of Crescent Class A Common Stock for each Vital share.

Capital raiseCrescent's offering of $600.0 million aggregate principal amount of its 8.375% Senior Notes due 2034.Concurrent tender offer of certain of its 9.250% Senior Notes due 2028.Redemption of certain of its 2028 Notes.Draw on Crescent's senior secured reserve-based revolving credit agreement and repayment of Vital's senior secured credit facility immediately following closing.Vital's standalone operations faced risks requiring additional equity and debt capital for significant asset acquisitions, which might not be available at a reasonable cost or at all.The combined company's increased market capitalization is expected to enhance its access to debt and equity capital markets.

Summary

  • Crescent Energy Company (Crescent) will acquire Vital Energy, Inc. (Vital) through a series of merger transactions.
  • Each outstanding share of Vital Common Stock will be converted into the right to receive 1.9062 shares of Crescent Class A Common Stock.
  • The implied value of the per share merger consideration was approximately $18.95 based on Crescent's closing price on August 22, 2025, and approximately $17.08 based on its closing price on November 10, 2025.
  • Post-merger, Crescent's existing stockholders are expected to hold approximately 77% of Crescent Class A Common Stock, while Vital's existing stockholders will hold approximately 23%.
  • Both the Crescent Board and the Vital Board unanimously recommend the merger proposals to their respective stockholders.
  • The mergers are expected to be completed by year-end 2025, subject to the satisfaction or waiver of various conditions.

Sentiment

Score: 8

Explanation: The filing outlines a strategic, accretive merger with significant synergies, increased scale, and improved financial positioning for the combined entity, despite inherent integration risks and the fixed exchange ratio. Both boards unanimously recommend the transaction.

Positives

  • The mergers are expected to be accretive on key financial metrics, including levered free cash flow per share, cash flow from operations per share, and NAV per share, beginning in 2026.
  • The combined company is anticipated to benefit from increased cash flows and a more robust free cash flow profile, strengthening its capital allocation framework for stockholder returns and debt reduction.
  • Crescent will gain entry into the Permian Basin through Vital's assets, primarily in the Midland and Delaware sub-basins.
  • The combined entity will be a leading U.S. oil and gas explorer and producer with approximately 1 million net acres across the Eagle Ford, Uinta, and Permian Basins, and a production base of approximately 397,000 barrels of oil equivalent per day.
  • The increased scale is expected to enhance competitiveness, facilitate future development, exploration, and acquisitions through increased cash flow, lower cost of capital, and more efficient capital expenditures.
  • The merger adds approximately 1,000 undeveloped locations, increasing Crescent's existing inventory by about 50% and supporting over a decade of development.
  • The combined company is projected to have one of the lowest production decline rates in its peer group.
  • Both Crescent and Vital have demonstrated leading sustainability practices, with expectations for continued improvements in the combined company.
  • Crescent's management team has a proven track record of successful merger and acquisition integrations.
  • The addition of two Vital-designated directors to the Crescent Board will bring valuable expertise and familiarity with Vital's assets and operations.
  • The mergers are intended to qualify as a tax-free reorganization for U.S. federal income tax purposes.
  • Crescent will continue to pay its base cash dividend of $0.12 per share quarterly.
  • Crescent can consummate the mergers without the need for additional third-party financing, and the merger agreement does not contain a financing covenant.
  • The incremental Management Fee payable to KKR Energy Assets Manager LLC due to the equity issuance from the merger will be capped at $9.0 million per annum.

Negatives

  • The fixed exchange ratio means Vital stockholders bear the risk of a decrease in Crescent Class A Common Stock's market price before the closing of the mergers.
  • There is no collar or value-based termination right for Vital stockholders in the merger agreement.
  • Significant risks are inherent in integrating the operations of Vital into Crescent, including the possibility that expected synergies may not be fully realized, and that successful integration will require substantial management resources, diverting attention from day-to-day business.
  • Both companies will incur substantial transaction and merger-related costs, many of which are payable regardless of whether the mergers are completed.
  • The completion of the mergers may trigger change-in-control or other provisions in certain agreements to which Vital is a party, potentially leading to termination or renegotiation on less favorable terms.
  • The potential for securities class action and derivative lawsuits could result in substantial costs and may delay or prevent the mergers from being completed.
  • The mergers may be completed even if material adverse changes occur that affect either party but do not permit termination under the agreement.
  • Vital stockholders are not entitled to dissenters or appraisal rights in connection with the mergers.
  • Current Vital stockholders will have a reduced ownership and voting interest (approximately 23%) in the combined company compared to their current ownership in Vital.
  • KKR's affiliate (the Series I Preferred Stockholder) will retain significant control over certain corporate matters, including the election of directors, in Crescent, which will reduce Vital stockholders' influence over management.
  • Crescent's reliance on the Manager (KKR Energy Assets Manager LLC) to manage its business and operations, with the allocation of personnel and resources generally within the Manager's discretion, could be a concern.
  • The combined company may record goodwill and other intangible assets that could become impaired, potentially resulting in material non-cash charges to future operating results.
  • Crescent's ability to utilize Vital's existing U.S. net operating loss (NOL) carryforwards (approximately $897 million) may be materially limited by Section 382 of the Code.
  • The market price of Crescent Class A Common Stock may fluctuate after the mergers and could decline if the anticipated benefits do not meet financial analysts' expectations.
  • Sales of substantial amounts of Crescent Class A Common Stock in the open market by former Vital stockholders could depress Crescent's stock price.
  • Crescent's results may suffer if it does not effectively manage its expanded operations following the mergers.
  • Crescent may be exposed to additional commodity price risks arising from Vital's existing hedging activities.
  • The unaudited pro forma financial statements are presented for illustrative purposes only and are not necessarily indicative of the combined company's future financial condition or results of operations.
  • The opinions of Crescent's and Vital's respective financial advisors will not reflect changes in circumstances between the signing of the Merger Agreement and the completion of the mergers.
  • Vital, as a standalone company, faced risks including difficulty in increasing production and reserves through acquisitions, challenges in competing with larger companies, potential need for additional equity/debt capital, and the risk of its stock continuing to trade at depressed multiples.

Risks

  • Reliance on Section 8(a) of the Securities Act for registration statement effectiveness could lead to adverse consequences, including the potential need for post-effective amendments, updated proxy statements, or a stop order, which could cause a stock price decline.
  • The fixed exchange ratio means Vital stockholders cannot be certain of the precise value of the merger consideration they will receive due to fluctuations in Crescent Class A Common Stock's market price.
  • The mergers are subject to a number of conditions, including stockholder and regulatory approvals, which if not fulfilled or delayed, may prevent completion or result in termination of the Merger Agreement.
  • Failure to complete the mergers could negatively impact the price of shares for both companies, as well as their respective ongoing and future businesses and financial results, and incur substantial costs.
  • Crescent's and Vital's directors, executive officers, and other affiliates may have interests in the mergers that are different from, or in addition to, the interests of their respective stockholders.
  • Current Crescent and Vital stockholders will have a reduced ownership and voting interest in the combined company after the consummation of the mergers.
  • The mergers are subject to the expiration or termination of the waiting period under the HSR Act, which could delay or prevent completion or lead to asset divestitures or other conditions.
  • The Merger Agreement subjects Vital and Crescent to restrictions on their respective business activities while the mergers are pending, potentially preventing them from pursuing certain business opportunities.
  • Uncertainties associated with the mergers may cause a loss of management personnel and other key employees, which could adversely affect the future business and operations of the combined company.
  • Crescent and Vital will incur significant transaction and merger-related costs, which may be in excess of those anticipated.
  • Completion of the mergers may trigger change in control or other provisions in certain agreements to which Vital is a party, including indebtedness and oil and gas leases, potentially leading to termination or renegotiation.
  • Crescent and Vital may be targets of securities class action and derivative lawsuits, which could result in substantial costs and may delay or prevent the mergers from being completed.
  • The mergers may be completed even though material adverse changes subsequent to the announcement, such as industry-wide changes or other events, may occur.
  • Vital stockholders are not entitled to appraisal rights under Delaware law in connection with the mergers.
  • After the mergers are completed, Vital stockholders will have their rights as stockholders governed by Crescent's organizational documents, leading to less influence over the combined company's management due to the Series I Preferred Stockholder's control.
  • If the mergers do not qualify as a reorganization within the meaning of Section 368(a) of the Code, Vital stockholders may be required to pay substantial U.S. federal income taxes.
  • The financial forecasts are based on various assumptions that may not be realized, and actual future results may vary materially.
  • The opinions of Crescent's and Vital's respective financial advisors will not reflect changes in circumstances between the signing of the Merger Agreement and the completion of the mergers.
  • Sales of substantial amounts of Crescent Class A Common Stock in the open market, by former Vital stockholders or otherwise, could depress Crescent's stock price.
  • The market price of Crescent Class A Common Stock will continue to fluctuate after the mergers and may decline if the benefits do not meet the expectations of financial analysts.
  • The market price of Crescent Class A Common Stock may be affected by factors different from those that historically have affected Vital Common Stock.
  • Crescent may incorporate Vital's hedging activities and be exposed to additional commodity price risks.
  • The combined company may record goodwill and other intangible assets that could become impaired, resulting in material non-cash charges.
  • Crescent's ability to utilize the existing U.S. net operating loss (NOL) carryforwards of Vital or its own NOL carryforwards may be materially limited by Section 382 of the Code.

Future Outlook

The combined company is expected to achieve accretion on key financial metrics starting in 2026, driven by increased cash flows, a stronger free cash flow profile, and an improved credit standing. This enhanced financial position is anticipated to support consistent capital returns to stockholders and debt reduction. The merger will establish a leading U.S. oil and gas explorer and producer with a diversified asset base across the Permian, Eagle Ford, and Uinta Basins, positioning it for sustainable value creation through strategic investing and accretive acquisitions.

Management Comments

  • David Rockecharlie (Crescent CEO): "Crescent has been following the continued acquisition and operational developments at Vital."
  • Jason Pigott (Vital CEO): "Vital continued to seek opportunities for enhanced operational scale and financial strength, and was open to considering a variety of strategic transactions."
  • Vital Board: "Vital faced significant challenges to maximizing shareholder value if it continued to operate on a stand-alone basis given its size, leverage profile and investor preferences for companies that were able to return capital to investors through dividends."
  • Vital Board: "Vital and its stockholders could realize significant benefits by increasing its operating scale, deleveraging and increasing its market capitalization."
  • Vital Board: "Vital stock was undervalued at such time."
  • Vital Board: "The most likely transaction to maximize stockholder value would be a stock-for-stock transaction with a larger, less leveraged publicly traded oil and gas company."
  • Crescent Board: "The Mergers will be accretive on key financial metrics beginning in 2026, including levered free cash flow per share, cash flow from operations per share and NAV per share."
  • Crescent Board: "The combined company will benefit from increased cash flows, further strengthening Crescents capital allocation framework by creating a more robust free cash flow profile, permitting the combined company to return capital to its stockholders and reduce debt."
  • Crescent Board: "The combination of Vitals and Crescents assets will permit Crescents entry into the Permian Basin through Vitals assets."
  • Crescent Board: "The increased scale of the combined company should permit it to compete more effectively and facilitate future development projects, exploration and acquisitions through increased cash flow, lower cost of capital and more efficient capital expenditures."
  • Crescent Board: "The combined company is expected to create an industry-leading mid-cap exploration and production company primed for sustainable value creation."

Industry Context

The announcement reflects a broader trend of consolidation within the U.S. oil and gas industry, particularly among small-to-mid-cap exploration and production companies. This trend is driven by the desire to achieve greater operational scale, improve financial strength, enhance access to capital markets, and increase market capitalization to attract investors who favor companies capable of returning capital through dividends. The merger positions the combined entity as a larger, more diversified player in key U.S. basins, aiming to leverage scale for competitive advantages in development, exploration, and acquisitions.

Comparison to Industry Standards

  • Vital Common Stock has consistently traded at a lower multiple compared to its larger market capitalization peers.
  • The proposed exchange ratio implies a 20.0% premium to Vital's closing price on August 22, 2025, a 26.3% premium to its 10-day volume-weighted average trading price, and a 15.0% premium to its 30-day volume-weighted average trading price, which the Vital Board considered to be the highest spot premium announced in a stock-for-stock oil and gas combination in over five years.
  • The combined company is expected to have one of the lowest production decline rates in its peer group, indicating strong asset quality and operational efficiency.
  • Houlihan Lokey's premiums paid analysis, comparing the merger's implied premiums to 26 precedent corporate exploration and production transactions, showed the merger's premiums were within or above the mean/median of those transactions, suggesting a favorable valuation for Vital stockholders.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorOne current director of CrescentTwo directors designated by VitalImmediately prior to, but conditioned on, the Effective TimeTo effect the appointment of Vital's designees and expand the board to twelve members.
DirectorNATwo directors designated by VitalAs of the Effective TimeTo add valuable expertise and familiarity with Vital's assets and operations to the Crescent Board.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe Crescent Board will increase to twelve directors, with two designated by Vital. These designees must satisfy NYSE independence requirements and be appointed to a standing committee.Immediately prior to, but conditioned on, the Effective TimeEnhances board diversity and expertise, provides Vital's perspective, but KKR's affiliate retains significant control over director elections.
Director Removal RestrictionsThe Series I Preferred Stockholder (KKR affiliate) agrees not to remove or replace Vital Director Designees for a period of two years following the Effective Time (except for cause).Effective TimeProvides stability for Vital's board representation within the combined company.
Preferred Stock Transfer RestrictionsThe Series I Preferred Stockholder (KKR affiliate) agrees not to indirectly transfer its shares of Crescent Preferred Stock for a period of three years following the Effective Time.Effective TimeProvides enhanced certainty regarding KKR's long-term involvement and control.
Management Fee StructureThe incremental Management Fee payable to KKR Energy Assets Manager LLC resulting from the equity issuance in the mergers will not exceed $9.0 million per annum.ClosingCaps the potential increase in management fees for KKR, addressing a potential conflict of interest related to the transaction's size.
Manager Incentive Plan Share LimitThe Manager Incentive Plan Share Limit may increase by up to 7,354,659 shares of Crescent Class A Common Stock on January 1, 2026, due to the Crescent Stock Issuance.January 1, 2026Increases the pool of potential equity awards for the Manager (KKR affiliate).
Manager PSU Award Target SharesThe target number of shares underlying the Manager PSU Award may increase by up to 5,883,727 shares due to the Crescent Stock Issuance.Effective TimeIncreases the potential performance-based equity awards for the Manager (KKR affiliate).
Stockholder Voting Rights (Crescent)Prior to the Trigger Date, the Series I Preferred Stockholder has full and exclusive authority to appoint the entire Crescent Board and has certain approval rights over fundamental corporate actions.OngoingVital stockholders will have less ability to influence Crescent's business and board composition than they currently do over Vital's management.
Stockholder Action Without Meeting (Crescent)Any action that may be taken at a meeting of Crescent stockholders may be taken without a meeting if consented to by the Crescent Board and the Series I Preferred Stockholder in writing.OngoingLimits the ability of minority stockholders to initiate actions without board and preferred stockholder consent.
Section 203 DGCL Applicability (Crescent)Crescent expressly elects not to be governed by Section 203 of the DGCL, which restricts business combinations with interested stockholders.OngoingPotentially makes Crescent more susceptible to certain types of takeovers or related party transactions that would otherwise be restricted.
Corporate Opportunity Doctrine (Crescent)The Crescent Charter renounces the corporate opportunity doctrine for KKR Participants in circumstances where it would conflict with their fiduciary duties or contractual obligations.OngoingAllows KKR and its affiliates to pursue opportunities that might otherwise be considered corporate opportunities for Crescent, potentially limiting Crescent's growth opportunities.

Legal Proceedings

  • Potential for securities class action and derivative lawsuits against Crescent, Vital, or their respective directors and officers related to the mergers.

Related Party Transactions

  • Henry Investor Agreement: Henry Investors, holding approximately 20% of Vital Common Stock, are required to vote in favor of the Vital Board's recommendation for the merger, subject to limited exceptions. Vital is obligated to use reasonable best efforts to enforce these obligations.
  • Crescent Support Agreements: Certain Crescent stockholders, including affiliates of John C. Goff and KKR, holding approximately 29% of Crescent Class A Common Stock and all Series I Preferred Stock, have agreed to vote in favor of the Crescent Issuance Proposal and against competing proposals.
  • Management Agreement Amendment: The incremental Management Fee payable to KKR Energy Assets Manager LLC (an affiliate of Crescent's Series I Preferred Stockholder) due to the equity issuance from the mergers will not exceed $9.0 million per annum.
  • Manager Incentive Plan Share Limit: The Manager Incentive Plan Share Limit, which benefits KKR Energy Assets Manager LLC, may increase by up to 7,354,659 shares of Crescent Class A Common Stock due to the Crescent Stock Issuance.
  • Manager PSU Award: The target number of shares underlying the Manager PSU Award, which benefits KKR Energy Assets Manager LLC, may increase by up to 5,883,727 shares due to the Crescent Stock Issuance.
  • KKR's affiliate (the Series I Preferred Stockholder) retains full and exclusive authority to appoint the entire Crescent Board and has certain approval rights over fundamental corporate actions, indicating significant control.
  • Certain Crescent officers and directors are employees of, or otherwise associated with, the Manager and its affiliates, and may benefit from the increases in Management Fee, Manager Incentive Plan Share Limit, and Manager PSU Award in a manner that differs from the interests of Crescent stockholders generally.

Stakeholder Impact

  • Shareholders (Vital): Will receive a fixed exchange ratio of Crescent stock, allowing participation in the combined company's future growth and dividends, but are exposed to Crescent's stock price fluctuations and will have reduced voting influence in the larger entity.
  • Shareholders (Crescent): Will experience dilution from the issuance of new shares but are expected to benefit from increased scale, diversification, and anticipated financial accretion.
  • Employees (Vital): Will receive 2025 annual bonuses (greater of target or actual performance), continued employment benefits for 12 months post-merger, and credit for prior service in new plans. Executive officers are eligible for accelerated equity vesting and potential severance benefits upon a qualifying termination.
  • Employees (Crescent): Current employees and executive officers are generally expected to continue in their positions.
  • Management (Vital): Executive officers will see accelerated vesting of outstanding incentive awards, potential severance payments and benefits upon a qualifying termination, and ongoing indemnification and insurance coverage. Two Vital designees will join the Crescent Board.
  • Management (Crescent): The current management team is expected to continue leading the combined company.
  • KKR Energy Assets Manager LLC (related party): Will benefit from a capped increase in the Management Fee, and potential increases in the Manager Incentive Plan Share Limit and Manager PSU Award target shares. It will also retain significant control over Crescent's board composition and certain corporate actions.
  • Creditors (Vital): The Vital Revolving Credit Facility is expected to be paid off and terminated. Vital's senior unsecured notes may trigger a repurchase offer if a change of control is accompanied by a ratings downgrade.
  • Customers and Suppliers: May experience disruptions or renegotiations of existing relationships due to the pendency and completion of the mergers.

Next Steps

  • Crescent and Vital stockholders will hold special meetings on December 12, 2025, to vote on merger-related proposals.
  • Crescent stockholders will vote on the Crescent Issuance Proposal and the Crescent Adjournment Proposal.
  • Vital stockholders will vote on the Vital Merger Proposal and the Vital Advisory Compensation Proposal.
  • The mergers are expected to be completed by year-end 2025, subject to the satisfaction or waiver of all conditions.
  • Crescent will file a registration statement for Parent Common Stock subject to Converted Options.
  • Crescent will take actions to ensure its Class A Common Stock issued to Vital stockholders is approved for listing on the NYSE.
  • Vital will take actions to delist Vital Common Stock from the NYSE and terminate its SEC registration.
  • Crescent intends to effect an internal reorganization for financing purposes promptly following the completion of the mergers.

Key Dates

DateDescription
September 13, 2023Date of the Henry Investor Agreement.
September 20, 2024Vital completed the Point Energy Acquisition, its largest acquisition to date.
October 30, 2024Houlihan Lokey and J.P. Morgan attended a Vital Board meeting to discuss strategic alternatives.
November 6, 2024Vital reported its third quarter financial and operating results.
December 3, 2024Crescent completed the Ridgemar Acquisition.
December 31, 2024Fiscal year-end for both Crescent and Vital; date for reserve reports and certain financial data.
January 10, 2025Mr. Pigott held a call with an investment banker representing Company G to discuss potential strategic transaction.
February 5, 2025Vital Board meeting to discuss strategic alternatives and market reactions to M&A activity.
May 15, 2024Date of the Agreement and Plan of Merger between Crescent and SilverBow Resources, Inc.
May 21, 2025Vital Board meeting where formal strategic review process was authorized.
June 17, 2025Vital and Company F entered into a confidentiality agreement; Vital and Crescent entered into a confidentiality agreement.
July 2025Crescent engaged Kirkland & Ellis LLP as outside legal counsel for the Potential Transaction; Crescent completed Notes Transactions.
July 29, 2025Crescent submitted an initial non-binding proposal to acquire Vital; bid deadline for Vital's sale process expired.
August 4, 2025Crescent announced its financial and operating results for the quarter ended June 30, 2025; Crescent provided Vital with its standalone unaudited financial forecast.
August 7, 2025Vital announced its financial and operating results for the quarter ended June 30, 2025.
August 15, 2025Jefferies was formally engaged as Crescent's financial advisor; Intrepid was formally engaged as the Crescent Special Committee's financial advisor.
August 21, 2025Vital executed an amendment to its engagement letter with Houlihan Lokey.
August 22, 2025Last trading day before the public announcement of the signing of the Merger Agreement; Reuters published a news article stating Crescent was in advanced talks to acquire Vital.
August 24, 2025Merger Agreement signed; Crescent Board, Crescent Special Committee, and Vital Board approved the merger; Jefferies and Intrepid rendered fairness opinions; Houlihan Lokey rendered fairness opinion; Parent Preferred Stockholder Approval obtained; Management Agreement Amendment entered.
August 25, 2025Joint press release announcing the Mergers; first public announcement of the Mergers.
September 16, 2025Crescent filed a Current Report on Form 8-K with pro forma statements of operations for the six months ended June 30, 2025 and for the year ended December 31, 2024.
September 29, 2025Crescent and Vital filed their respective notification and report forms under the HSR Act.
October 16, 2025Record date for the Crescent Special Meeting.
October 21, 2025Date used for calculating outstanding Vital equity awards for executive officers.
October 22, 2025Record date for the Vital Special Meeting.
November 3, 2025Crescent and Vital filed Quarterly Reports on Form 10-Q for the quarter ended September 30, 2025.
November 10, 2025Last practicable trading day before the date of the joint proxy statement/prospectus.
November 12, 2025Date of the joint proxy statement/prospectus and first mailing to stockholders.
November 28, 2025Date commencing availability of stockholder lists for inspection for both Crescent and Vital special meetings.
December 5, 2025Deadline for Crescent and Vital stockholders to request documents for timely delivery before their respective special meetings.
December 10, 2025Deadline for Vital stockholders to pre-register for the virtual special meeting (10:00 a.m. CT).
December 11, 2025Deadline for Crescent stockholders to submit proxies by phone or internet (11:59 p.m. ET); deadline for Vital stockholders to submit proxies by phone or internet (10:59 p.m. CT); deadline for Crescent mail proxies (11:59 p.m. ET); deadline for Vital mail proxies (10:59 p.m. CT); deadline for Crescent stockholders to submit questions in advance (close of business).
December 12, 2025Date of the Crescent Special Meeting (10:00 a.m. CT) and the Vital Special Meeting (10:00 a.m. CT).
December 15, 2025Assumed closing date for calculating golden parachute compensation.
March 15, 2026Latest payment date for 2025 annual bonuses for Vital employees.
March 31, 2026End Date for merger completion, after which either party may terminate the Merger Agreement if not completed.

Recommendation

hold

The merger presents a compelling strategic rationale, promising increased scale, diversification, and expected financial accretion for the combined entity, which are positive indicators. However, the fixed exchange ratio exposes Vital stockholders to market price volatility of Crescent's stock, and the significant control retained by KKR's affiliate in Crescent's governance structure could be a point of concern for minority shareholders. The substantial transaction costs and inherent integration risks also warrant a cautious approach. Given this balance of strong potential benefits and notable risks, a 'Hold' recommendation is appropriate for existing investors to monitor the integration process and market performance of the combined company.

Keywords

Merger, Acquisition, Oil and Gas, Energy, Permian Basin, Eagle Ford, Uinta Basin, Stock-for-Stock, SEC Filing, DEFM14A, Vital Energy, Crescent Energy, CRGY, VTLE, Shareholder Vote, Corporate Governance, Risk Factors, Financial Performance, Integration, KKR, Commodity Prices, NOL Carryforwards

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.